Citadel Advisors
FMS icon

Citadel Advisors’s Fresenius Medical Care FMS Stock Holding History

Citadel Advisors’s Portfolio FMS Stock Details FMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$473K Sell
20,900
-900
-4% -$20.2K ﹤0.01% 9990
2026
Q1 		$492K Buy
21,800
+10,700
+96% +$246K ﹤0.01% 9360
2025
Q4 		$264K Buy
+11,100
New +$276K ﹤0.01% 10420
2025
Q3 		– Sell
-15,000
Closed -$429K – 13192
2025
Q2 		$429K Sell
15,000
-19,000
-56% -$510K ﹤0.01% 8991
2025
Q1 		$847K Buy
34,000
+10,100
+42% +$240K ﹤0.01% 7326
2024
Q4 		$541K Sell
23,900
-32,600
-58% -$708K ﹤0.01% 8377
2024
Q3 		$1.2M Buy
56,500
+19,100
+51% +$376K ﹤0.01% 6491
2024
Q2 		$714K Buy
37,400
+31,100
+494% +$634K ﹤0.01% 7321
2024
Q1 		$121K Buy
6,300
+5,200
+473% +$103K ﹤0.01% 11090
2023
Q4 		$22.9K Sell
1,100
-18,200
-94% -$350K ﹤0.01% 12508
2023
Q3 		$416K Sell
19,300
-12,800
-40% -$311K ﹤0.01% 8480
2023
Q2 		$768K Buy
32,100
+8,300
+35% +$190K ﹤0.01% 7013
2023
Q1 		$506K Buy
23,800
+4,300
+22% +$82.3K ﹤0.01% 8283
2022
Q4 		$319K Buy
19,500
+6,200
+47% +$91.9K ﹤0.01% 9185
2022
Q3 		$187K Sell
13,300
-3,100
-19% -$58.6K ﹤0.01% 10467
2022
Q2 		$409K Buy
16,400
+4,500
+38% +$134K ﹤0.01% 9101
2022
Q1 		$401K Buy
11,900
+4,200
+55% +$138K ﹤0.01% 9893
2021
Q4 		$250K Buy
+7,700
New +$253K ﹤0.01% 11352

Other funds holding FMS

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.63B AUM 45.28% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return

Citadel Advisors's FMS Position: Q2 2026 in Review

Citadel Advisors reduced its Fresenius Medical Care (FMS) stake by 33% in Q2 2026, selling an estimated $416K and leaving 38,048 shares worth $860K. The position accounts for ﹤0.01% of the portfolio, ranked #8584.

Citadel Advisors first reported a position in FMS in Q2 2016 and has held it in 37 quarters since. The position peaked at $16.3M in Q3 2022. 234 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • Citadel Advisors held 38,048 shares of Fresenius Medical Care worth $860K as of Q2 2026.
  • Citadel Advisors sold 18,530 Fresenius Medical Care shares in Q2 2026, an estimated $416K.
  • Fresenius Medical Care made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #8584 holding.
  • Citadel Advisors first reported a position in Fresenius Medical Care in Q2 2016 and has held it in 37 quarters since.
  • Citadel Advisors's Fresenius Medical Care position peaked at $16.3M in Q3 2022.
  • 234 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.